Getting a medicine to market in Australia, even a non-prescription one particular, involves substantial exploration and expense. It might be too much for compact cannabis producers to tackle, and also a turn-off for giant pharmaceutical businesses if that investment decision is for the expense of approaching blockbuster medicine.Ash Richardson, who